Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 15/20 | 0.54 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17437797 | 0.90 | ALDH1A1 (0.52) | TBXAS1EGLN3MEN1LMNAKMT2A | |
| SCHEMBL15506132 | 0.90 | TBXAS1 (0.54) | TBXAS1EGLN3MEN1KMT2A | |
| SCHEMBL15506130 | 0.88 | TBXAS1 (0.56) | TBXAS1MEN1LMNAKMT2AKDM4E | |
| SCHEMBL1071597 | 0.85 | TBXAS1 (0.50) | TBXAS1EGLN3MEN1LMNAKMT2A | |
| SCHEMBL10072238 | 0.83 | TBXAS1 (0.59) | TBXAS1EGLN3MEN1LMNAKMT2A | |
| SCHEMBL8032821 | 0.83 | TBXAS1 (0.50) | TBXAS1EGLN3MEN1LMNAKMT2A | |
| SCHEMBL24517734 | 0.82 | EGLN3 (0.53) | TBXAS1EGLN3MEN1LMNAKMT2A | |
| SCHEMBL11035419 | 0.82 | ALDH1A1 (0.47) | TBXAS1EGLN3KMT2AALDH1A1KDM4E | |
| SCHEMBL7461666 | 0.81 | ALDH1A1 (0.50) | TBXAS1EGLN3ALDH1A1 | |
| SCHEMBL10656066 | 0.81 | TBXAS1 (0.52) | TBXAS1EGLN3MEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116315029-B | Electrolyte and lithium battery containing same | 张家港市国泰华荣化工新材料有限公司 | 2024-03-29 | — | — | CN | claimed |
| WO-2023116005-A1 | NONAQUEOUS ELECTROLYTE AND LITHIUM ION BATTERY CONTAINING SAME | 张家港市国泰华荣化工新材料有限公司 | 2023-06-29 | — | — | WO | claimed |
| CN-116315029-A | Electrolyte and lithium battery containing same | 张家港市国泰华荣化工新材料有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-111303040-A | Method for preparing imidazole-1-acetic acid by one-pot method | 武汉工程大学 | 2020-06-19 | — | — | CN | claimed |
| CN-116315029-B | Electrolyte and lithium battery containing same | 张家港市国泰华荣化工新材料有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-116315083-B | Nonaqueous electrolyte and lithium ion battery containing same | 张家港市国泰华荣化工新材料有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-11762287-B2 | Onium salt compound, chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-19 | — | — | US | disclosed |
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
| WO-2023116005-A1 | NONAQUEOUS ELECTROLYTE AND LITHIUM ION BATTERY CONTAINING SAME | 张家港市国泰华荣化工新材料有限公司 | 2023-06-29 | — | — | WO | disclosed |
| CN-116315083-A | Nonaqueous electrolyte and lithium ion battery containing same | 张家港市国泰华荣化工新材料有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116315029-A | Electrolyte and lithium battery containing same | 张家港市国泰华荣化工新材料有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-20090246686-A1 | POLYMER, POLYMER PREPARATION METHOD, RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-10-01 | — | — | US | disclosed |
| US-20090202485-A1 | HETEROARYL-CONTAINING TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS | ENANTA PHARMACEUTICALS, INC. | 2009-08-13 | — | — | US | disclosed |
| EP-2033966-A2 | Movel photoacid generators, resist compositons, and patterning processes | Shin-Etsu Chemical Co., Ltd. (JP) | 2009-03-11 | — | — | EP | disclosed |
| US-20090061358-A1 | NOVEL PHOTOACID GENERATOR, RESIST COMPOSITION, AND PATTERNING PROCESS | PROXIMAL SYSTEMS CORPORATION | 2009-03-05 | — | — | US | disclosed |
| WO-2008098886-A2 | METHOD FOR PRODUCING (METH)ACRYLATES OF N-HYDROXYALKYLATED IMIDAZOLES | BASF SE (DE) | 2008-08-21 | — | — | WO | disclosed |
| US-20080102405-A1 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. | 2008-05-01 | — | — | US | disclosed |
| US-7141351-B2 | Basic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2006-11-28 | — | — | US | disclosed |
| US-20040234884-A1 | Basic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SLC6A9, SLC6A5, REN | TBXAS1 4437/4885EGLN3 4518/4885MEN1 3242/4885 |
| US-20080102405-A1 | Nitrogen-containing organic compound, resist composition and patterning process | MDM4, MUS81, NOP2 | TBXAS1 2649/4885EGLN3 1123/4885MEN1 1226/4885 |
| US-20090061358-A1 | NOVEL PHOTOACID GENERATOR, RESIST COMPOSITION, AND PATTERNING PROCESS | RER1, CRY1, CYP21A2 | TBXAS1 1300/4885EGLN3 419/4885MEN1 718/4885 |
| US-11762287-B2 | Onium salt compound, chemically amplified resist composition and patterning process | IDUA, SLC6A5, SLC6A9 | TBXAS1 4636/4885EGLN3 4826/4885MEN1 3334/4885 |
| US-20090202485-A1 | HETEROARYL-CONTAINING TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS | PRSS1, CTSC, SPINT2 | TBXAS1 3050/4885EGLN3 2154/4885MEN1 4578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.